Search

everythinglearnresearchcommunity

for

Search:↓

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

A new compound effectively inhibits human 5α-reductase 1.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Pranlukast and mirabegron may work as new diabetes drugs.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

Noggin promotes skin tumors by activating Wnt and Shh pathways.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Pantethine may boost the immune system's ability to fight sarcoma.

SUN11602 and ONO-1301 could help in skin healing and creating artificial skin.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

α-MSH increases melanin production in moulting hair follicles, while AVT inhibits it.

Steroid pulse therapy improved symptoms in a man with Satoyoshi syndrome.

The study found that imaging might miss small ovarian tumors causing high testosterone, and suggested using certain testosterone levels and treatment responses to identify these tumors.

Blocking mTORC1 reduces skin tumor growth in mice.

Vitamin D3 analogs can promote hair growth in mice genetically prone to hair loss.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

Analog 23 is a promising compound for prostate cancer treatment.

Tirzepatide may improve hair loss by reducing insulin resistance.

Glibenclamide slows breast cancer cell growth by stopping cell division.